High-dose interleukin-2 and interferon as first-line immunotherapy for metastatic melanoma: long-term follow-up in a large unselected Danish patient cohort.

Saved in:
Bibliographic Details
Title: High-dose interleukin-2 and interferon as first-line immunotherapy for metastatic melanoma: long-term follow-up in a large unselected Danish patient cohort.
Authors: Bastholt, Lars1 (AUTHOR) lars.bastholt@rsyd.dk, Svane, Inge Marie2 (AUTHOR), Bjerregaard, Jon Kroll1 (AUTHOR), Herrstedt, Jørn1 (AUTHOR), Hróbjartsson, Asbjørn3 (AUTHOR), Schmidt, Henrik4 (AUTHOR)
Source: European Journal of Cancer. Jul2019, Vol. 115, p61-67. 7p.
Database: Academic Search Ultimate
Description
ISSN:09598049
DOI:10.1016/j.ejca.2019.03.023